Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu2) Negative Allosteric Modulators (NAMs) Based on Functionalized Pyrazolo[1,5-a]pyrimidine-5-carboxamide and Thieno[3,2-b]pyridine-5-carboxamide Cores-Reference-Cited by-同舟云学术

Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu2) Negative Allosteric Modulators (NAMs) Based on Functionalized Pyrazolo[1,5-a]pyrimidine-5-carboxamide and Thieno[3,2-b]pyridine-5-carboxamide Cores

Published:2018-10-23 Issue:1 Volume:62 Page:378-384
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Childress Elizabeth S.,Wieting Joshua M.,Felts Andrew S.,Breiner Megan M.,Long Madeline F.,Luscombe Vincent B.,Rodriguez Alice L.,Cho Hyekyung P.,Blobaum Anna L.,Niswender Colleen M.¹,Emmitte Kyle A.^ORCID,Conn P. Jeffrey¹,Lindsley Craig W.^ORCID

Affiliation:

1. Vanderbilt Kennedy Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States,

Funder

National Institute of Mental Health

National Institutes of Health

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b01266

Reference25 articles.